rewirebio.iobenchmarks
Benchmark

Talos 2026 evaluation and reanalysis study

Published-study grouping of the catalogued evaluation protocols. This grouping does not claim an executable suite, full-paper extraction or independent clinical validation.

14 evaluations · 82 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

14 recorded evaluations, 82 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.

View coverage and remaining gaps across all benchmarks

Results

Results are available, but no reviewed comparison panel is linked in this release.

All evaluations

14 evaluations · 82 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Exomiser v14 default, Talos 2026 comparisonProtocol: Exomiser rank-budget recovery in ACG trios
Dataset: ACG trios: Exomiser SNV/indel comparison as reported in Results
172 Count (rank: any)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Exomiser v14 ACG trio rank-budget evaluation

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Comparison with other tools, rank all
Configuration: Exomiser v14 default, Talos 2026 comparisonProtocol: Exomiser rank-budget recovery in ACG trios
Dataset: ACG trios: Exomiser SNV/indel comparison as reported in Results
89% Recall (rank: any)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Exomiser v14 ACG trio rank-budget evaluation

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Comparison with other tools, rank all
Configuration: Exomiser v14 default, Talos 2026 comparisonProtocol: Exomiser rank-budget recovery in ACG trios
Dataset: ACG trios: Exomiser SNV/indel comparison as reported in Results
127 Count (rank: top 1)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Exomiser v14 ACG trio rank-budget evaluation

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Comparison with other tools, rank top1
Configuration: Exomiser v14 default, Talos 2026 comparisonProtocol: Exomiser rank-budget recovery in ACG trios
Dataset: ACG trios: Exomiser SNV/indel comparison as reported in Results
65% Top-1 accuracy
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Exomiser v14 ACG trio rank-budget evaluation

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Comparison with other tools, rank top1
Configuration: Exomiser v14 default, Talos 2026 comparisonProtocol: Exomiser rank-budget recovery in ACG trios
Dataset: ACG trios: Exomiser SNV/indel comparison as reported in Results
164 Count (rank: top 10)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Exomiser v14 ACG trio rank-budget evaluation

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Comparison with other tools, rank top10
Configuration: Exomiser v14 default, Talos 2026 comparisonProtocol: Exomiser rank-budget recovery in ACG trios
Dataset: ACG trios: Exomiser SNV/indel comparison as reported in Results
85% Top-10 accuracy
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Exomiser v14 ACG trio rank-budget evaluation

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Comparison with other tools, rank top10
Configuration: Exomiser v14 default, Talos 2026 comparisonProtocol: Exomiser rank-budget recovery in ACG trios
Dataset: ACG trios: Exomiser SNV/indel comparison as reported in Results
157 Count (rank: top 5)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Exomiser v14 ACG trio rank-budget evaluation

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Comparison with other tools, rank top5
Configuration: Exomiser v14 default, Talos 2026 comparisonProtocol: Exomiser rank-budget recovery in ACG trios
Dataset: ACG trios: Exomiser SNV/indel comparison as reported in Results
81% Top-5 accuracy
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Exomiser v14 ACG trio rank-budget evaluation

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Comparison with other tools, rank top5
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
5.1% Diagnostic yield (additional yield from reanalysis)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Review of Talos output
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
221 Count (diagnoses: first cycle)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Twenty-nine cycles
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
92% Proportion (diagnoses: first cycle)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Twenty-nine cycles
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
109 Count (diagnoses: improved analysis)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning More than half
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
45% Proportion (diagnoses: improved analysis)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning More than half
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
20 Count (diagnoses: later cycles)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Twenty-nine cycles
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
8% Proportion (diagnoses: later cycles)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Twenty-nine cycles
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
5 New candidates per 1000 cases per cycle
variants-per-1000-cases-per-cycle · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning During iterative reanalysis
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
241 Count (diagnoses: new confirmed)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Review of Talos output
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
78 Count (diagnoses: new gene-disease evidence)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning More than half
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
32% Proportion (diagnoses: new gene-disease evidence)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning More than half
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
54 Count (diagnoses: new variant evidence)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning More than half
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
22% Proportion (diagnoses: new variant evidence)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning More than half
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
238 Count (newly diagnosed individuals)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Review of Talos output
Configuration: Talos default filtering, 2026 studyProtocol: Talos diagnosis recovery and workload: ACG full
Dataset: Talos ACG full evaluation cohort
523 Count (candidate variants flagged)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos default: ACG full

Not reported

Aggregation: total

Talos Table 1: complete evaluation cohort outcomes · Table 1, ACG full, default, Candidate variants
Configuration: Talos default filtering, 2026 studyProtocol: Talos diagnosis recovery and workload: ACG full
Dataset: Talos ACG full evaluation cohort
1.3 Candidates per case
variants-per-proband · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos default: ACG full

Not reported

Aggregation: table ratio

Talos Table 1: complete evaluation cohort outcomes · Table 1, ACG full, default, Candidates per proband
Configuration: Talos default filtering, 2026 studyProtocol: Talos diagnosis recovery and workload: ACG full
Dataset: Talos ACG full evaluation cohort
2.8 Candidates per diagnosis
variants-per-diagnosis · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos default: ACG full

Not reported

Aggregation: table ratio

Talos Table 1: complete evaluation cohort outcomes · Table 1, ACG full, default, Candidates per diagnoses

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Methods and evaluation design

Procedure, tasks and evaluated configurations

Evaluation design

Benchmarks bring together tasks and protocols. A task describes the biological question; a protocol defines a particular test.

These source-backed links do not make different protocols or scores interchangeable.

Baseline coverage

Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.

0 of 16 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.

Baseline status by linked protocol

Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)

Coverage is derived from release 2026-11-21-c8bea25e5abb. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.

Run this benchmark

Choose a concrete protocol before running an evaluation. Its inputs, split and scoring rules determine which results can be compared.

Run instructions

No runnable recipe has been reviewed for this benchmark. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID uc-clinical-20260930-benchmark-talos-study.

Source locator: Table1; Results comparison with other tools and iterative reanalysis

Related records

Suggest a correction